Measurement of Inorganic Pyrophosphate in Biological Fluids, ELEVATED LEVELS IN SOME PATIENTS WITH OSTEOARTHRITIS, PSEUDOGOUT, ACROMEGALY, AND UREMIA
AUTOR(ES)
Silcox, Donald C.
RESUMO
A rapid and relatively simple method for measurement of inorganic pyrophosphate (PPi) in biological samples has been described. The mean ±SEM of plasma samples from 94 normal subjects was 1.8±0.06 μM, giving a normal range (99% confidence limits) of 0.16 - 3.40 μmol/liter. Analysis of 17 plasma samples in duplicate showed a standard deviation of 0.18, giving a 99% probability that a single determination of plasma PPi would be ±0.68 μM of the true value.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=302467Documentos Relacionados
- Pyrophosphohydrolase activity and inorganic pyrophosphate content of cultured human skin fibroblasts. Elevated levels in some patients with calcium pyrophosphate dihydrate deposition disease.
- Pathogenesis of chondrocalcinosis and pseudogout. Metabolism of inorganic pyrophosphate and production of calcium pyrophosphate dihydrate crystals.
- Association between synovial fluid levels of inorganic pyrophosphate and short term radiographic outcome of knee osteoarthritis.
- Plasminogen activators and their inhibitors in synovial fluids from normal, osteoarthritis, and rheumatoid arthritis knees.
- Serum and synovial fluid adenosine deaminase activity in patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis.
